Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system

Journal of the American College of Cardiology

Volumn 30, Issue 1, 1997, Pages 233-236

  Gold, Michael R ^a   Kavesh, Neal G ^a   Peters, Robert W ^a   Shorofsky, Stephen R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WAVEFORM;

ATRIAL FIBRILLATION; CHRONIC DISEASE; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0030740114     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00115-0     Document Type: Article

References (24)

1. Saksena S. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. PACE. 16:1993;202-207.
2. Kleman JM, Castle LW, Kidwell GA, et al. Nonthoracotomy - versus thoracotomy - implantable defibrillators intention-to-treat comparison of clinical outcomes . Circulation. 90:1994;2833-2842.
3. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator a comparison of epicardial and endocardial lead systems . Circulation. 92:1995;59-65.
4. Venditti FJ, O'Connell M, Martin DT, Shahian DM. Transvenous cardioverter defibrillators cost implications of a less invasive approach . PACE. 18:1995;711-715.
5. Bardy GH, Hofer B, Johnson G, et al. Implantable transvenous cardioverter-defibrillators. Circulation. 87:1993;1152-1168.
6. Hauser RG, Kurschinski DT, McVeigh K, Thomas A, Mower MM. Clinical results with nonthoracotomy ICD systems. PACE. 16:1993;141-148.
7. Vendetti FJ, Martin DT, Vassolas G, Bowen S. Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator. Circulation. 89:1994;216-223.
8. Hsia HH, Mitra RL, Flores BT, Marchlinski FE. Early postoperative increase in defibrillation threshold with nonthoracotomy system in humans. PACE. 17:1994;1166-1173.
9. Poole JE, Bardy GH, Dolack GL, Kudenchuk PJ, Anderson J, Johnson G. Serial defibrillation threshold measures in man a prospective controlled study . J Cardiovasc Electrophysiol. 6:1995;19-25.
10. Martin DT, John R, Venditti FJ. Increase in defibrillation threshold in non-thoracotomy implantable defibrillators using a biphasic waveform. Am J Cardiol. 76:1995;263-266.
11. Tummula RV, Riggio DR, Peters RW, Shorofsky SR, Gold MR. Chronic rise in defibrillation threshold with a hybrid lead system. Am J Cardiol. 78:1996;309-312.
12. Schwartzman D, Callans DJ, Gottlieb CD, Heo J, Marchlinski FE. Early postoperative rise in defibrillation threshold in patients with nonthoracotomy defibrillation lead systems attenuation with biphasic shock waveforms . J Cardiovasc Electrophysiol. 7:1996;483-493.
13. Schwartzman D, Nallamothu N, Callans DF, Preminger MW, Gottlieb CD, Marchlinski FE. Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. J Am Coll Cardiol. 26:1995;776-786.
14. Bardy GH, Johnson G, Poole JE, et al. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation. 88:1993;543-547.
15. Gold MR, Shorofsky SR. Transvenous defibrillation lead systems. J Cardiovasc Electrophysiol. 7:1996;570-580.
16. Shorofsky SR, Gold MR. Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol. 78:1996;313-316.
17. Singer I, Lang D. The defibrillation threshold. Kroll MW, Lehmann MH. Implantable Cardioverter Defibrillator Therapy The Engineering-Clinical Interface . 1996;89-129 Kluwer Academic, Norwell (MA).
18. Strickberger SA, Hummel JD, Horwood LE, et al. Effect of shock polarity on ventricular defibrillation threshold using a transvenous lead system. J Am Coll Cardiol. 24:1994;1069-1072.
19. Kirk MM, Shorofsky SR, Khalighi K, Kavesh NG, Peters RW, Gold MR. Chronic rise in monophasic defibrillation thresholds with a transvenous lead system. Am J Cardiol. 79:1997;679-681.
20. Kerber RE, Martins JB, Kienzle MG, et al. Energy, current, and success in defibrillation and cardioversion clinical studies using an automated impedance-based method of energy adjustment . Circulation. 77:1988;1038-1046.
21. Lerman BB, DiMarco JP, Haines DE. Current-based versus energy-based ventricular defibrillation a prospective study . J Am Coll Cardiol. 12:1988;1259-1264.
22. Singer I, Lang D. Defibrillation threshold clinical utility and therapeutic implications . PACE. 15:1992;932-949.
23. Rattes MF, Jones DL, Sharma AD, Klein GJ. Defibrillation threshold a simple and quantitative estimate of the ability to defibrillate . PACE. 10:1987;70-77.
24. Rattes MF, Jones DL, Sohla A, Sharma AD, Jarvis E, Klein GJ. Defibrillation with the sequential pulse technique reproducibility with repeated shocks . Am Heart J. 111:1986;874-878.